[Retracted] Perioperative Management and Long-Term Outcomes in Ocular Cicatricial Pemphigoid Patients Undergoing Cataract Surgery

<table class="table-group" id="tab5"><tr><td><table class="table"><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr class="thead"><td class="align_left">Score</td><td class="align_center">Meibomian gland coloboma range</td></tr><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr><td class="align_left">0</td><td class="align_center">No coloboma</td></tr><tr><td class="align_left">1</td><td class="align_center">&lt;1/3 proportion</td></tr><tr><td class="align_left">2</td><td class="align_center">1/3~2/3 proportion</td></tr><tr><td class="align_left">3</td><td class="align_center">&gt;2/3 proportion</td></tr><tr class="table-tr"><td colspan="2"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

<div>The score of meibomian gland coloboma range.</div>

Oxidative Medicine and Cellular Longevity

tab5

Table 5

Table 5: [Retracted] Perioperative Management and Long-Term Outcomes in Ocular Cicatricial Pemphigoid Patients Undergoing Cataract Surgery 